Wong WWL - Search Results

1

Feasibility of hepatitis C elimination by screening and treatment alone in high-income countries.

Tian F, Forouzannia F, Feng Z, Biondi MJ, Mendlowitz AB, Feld JJ, Sander B, Wong WWL. Tian F, et al. Among authors: wong wwl. Hepatology. 2024 Mar 13. doi: 10.1097/HEP.0000000000000779. Online ahead of print. Hepatology. 2024. PMID: 38478751

2

Cost-effectiveness of screening for hepatitis C in Canada.

Wong WWL, Tu HA, Feld JJ, Wong T, Krahn M. Wong WWL, et al. Among authors: wong t. CMAJ. 2015 Feb 17;187(3):E110-E121. doi: 10.1503/cmaj.140711. Epub 2015 Jan 12. CMAJ. 2015. PMID: 25583667 Free PMC article.

3

Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis.

Wong WW, Hicks LK, Tu HA, Pritchard KI, Krahn MD, Feld JJ, Chan KK. Wong WW, et al. Breast Cancer Res Treat. 2015 Jun;151(3):639-52. doi: 10.1007/s10549-015-3382-7. Epub 2015 May 12. Breast Cancer Res Treat. 2015. PMID: 25962692

4

A Parallel Sliding Region Algorithm to Make Agent-Based Modeling Possible for a Large-Scale Simulation: Modeling Hepatitis C Epidemics in Canada.

Wong WW, Feng ZZ, Thein HH. Wong WW, et al. IEEE J Biomed Health Inform. 2016 Nov;20(6):1538-1544. doi: 10.1109/JBHI.2015.2471804. Epub 2015 Aug 21. IEEE J Biomed Health Inform. 2016. PMID: 26302524

5

The cost-utility of integrated cervical cancer prevention strategies in the Ontario setting - Can we do better?

Sander B, Wong WW, Yeung MW, Ormanidhi O, Atkin K, Murphy J, Krahn M, Deeks SL. Sander B, et al. Vaccine. 2016 Apr 7;34(16):1936-44. doi: 10.1016/j.vaccine.2016.02.016. Epub 2016 Feb 15. Vaccine. 2016. PMID: 26892739

6

Drug therapies for chronic hepatitis C infection: a cost-effectiveness analysis.

Wong WW, Lee KM, Singh S, Wells G, Feld JJ, Krahn M. Wong WW, et al. CMAJ Open. 2017 Feb 3;5(1):E97-E108. doi: 10.9778/cmajo.20160161. eCollection 2017 Jan-Mar. CMAJ Open. 2017. PMID: 28401125 Free PMC article.

7

Model-based projection of health and economic effects of screening for hepatitis C in Canada.

Wong WWL, Erman A, Feld JJ, Krahn M. Wong WWL, et al. CMAJ Open. 2017 Aug 25;5(3):E662-E672. doi: 10.9778/cmajo.20170048. CMAJ Open. 2017. PMID: 28851700 Free PMC article.

8

Estimating chronic hepatitis C prognosis using transient elastography-based liver stiffness: A systematic review and meta-analysis.

Erman A, Sathya A, Nam A, Bielecki JM, Feld JJ, Thein HH, Wong WWL, Grootendorst P, Krahn MD. Erman A, et al. Among authors: wong wwl. J Viral Hepat. 2018 May;25(5):502-513. doi: 10.1111/jvh.12846. Epub 2018 Jan 24. J Viral Hepat. 2018. PMID: 29239068 Review.

9

Population-based estimate of hepatitis C virus prevalence in Ontario, Canada.

Bolotin S, Feld JJ, Garber G, Wong WWL, Guerra FM, Mazzulli T. Bolotin S, et al. Among authors: wong wwl. PLoS One. 2018 Jan 23;13(1):e0191184. doi: 10.1371/journal.pone.0191184. eCollection 2018. PLoS One. 2018. PMID: 29360823 Free PMC article.

10

HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.

van Tilborg M, Al Marzooqi SH, Wong WWL, Maan R, Vermehren J, Maasoumy B, Mazzulli T, Bolotin S, Garber G, Guerra F, Flud CR, Kowgier M, Janssen HL, de Knegt RJ, Pawlotsky JM, Cloherty GA, Duarte-Rojo A, Sarrazin C, Wedemeyer H, Feld JJ. van Tilborg M, et al. Among authors: wong wwl. Lancet Gastroenterol Hepatol. 2018 Dec;3(12):856-864. doi: 10.1016/S2468-1253(18)30271-1. Epub 2018 Sep 28. Lancet Gastroenterol Hepatol. 2018. PMID: 30274834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page